# DILTIAZEM HYDROCHLORIDE
> **ANDA216327** · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2023-04-06
## Drug
- **FDA Application Number:** ANDA216327
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DILTIAZEM HYDROCHLORIDE
- **Generic name:** DILTIAZEM HYDROCHLORIDE
- **Active ingredients:** DILTIAZEM HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** SCIEGEN PHARMS
- **Manufacturer:** ScieGen Pharmaceuticals, Inc.
- **First approval:** 2023-04-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216327)
---
*AI Analytics · CC0 1.0*